Objective: To assess whether obese women with advanced-stage ovarian cancer undergoing primary cytoreduction surgery were at increased risk of suboptimal cytoreduction and complications during the operative and postoperative period as compared to nonobese women.
Study design: A retrospective, case-control study of all cases of advanced-stage epithelial ovarian cancer managed surgically at Johns Hopkins Hospital between January 1, 1990, and December 31, 1999.
Results: Obese patients were as likely as nonobese patients to undergo optimal cytoreduction at surgery. Obese patients were more likely than nonobese patients to be high-risk anesthesia candidates and more likely than nonobese patients to have tumors >20 cm at surgery. Obese patients were not at greater risk of surgical or postoperative complications than were nonobese patients.
Conclusion: Obesity is not a risk factor for suboptimal surgical management of advanced-stage ovarian cancer.